{
  "id": 20817304,
  "title": "US panel warns of China’s biotech rise, fuelling push to curb ties as Chinese firms unfazed",
  "url": "https://urgent.news/2026/11/19/us-panel-warns-of-chinas-biotech-rise-fuelling-push-to-curb-ties-as",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-19T23:00:05.000Z",
  "source": {
    "name": "SCMP Business",
    "slug": "scmp-business",
    "url": "https://www.scmp.com/business/china-business/article/3375100/us-panel-warns-chinas-biotech-rise-fuelling-push-curb-ties-chinese-firms-unfazed"
  },
  "original_language": "en",
  "account": null,
  "summary": "Fresh warnings from a US congressional advisory body about the rapid rise of China’s biopharmaceutical sector are fuelling Washington’s push to curb cross-border ties, analysts said, though China’s industry appears largely unfazed. China was gaining a “competitive advantage” in biopharmaceuticals, and Western firms were increasingly paying large upfront fees to license Chinese drugs thanks to the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}